Caladrius Biosciences Inc., a clinical-stage biopharmaceutical company based in Basking Ridge, has been on the hunt for “strategic development opportunities” this past year, according to President and ...

On Wednesday, shares of clinical-stage biopharmaceutical company Caladrius Biosciences (CLBS) took off by a whopping 110%. However, the surge did not come off the back of a treatment’s regulatory ...

Moss revealed a fourth playable character in Caladrius called… Caladrius. It’s a giant fiery bird with swirling homing shots and option-like gunpods depending on which Element Shot you pick. Each ...

BASKING RIDGE, N.J. and SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed ...

Moss, known for developing the Raiden series, explained the Element Shoot system for their upcoming shoot ‘em up, Caladrius. The Element Shoot is a special attack that makes each character in ...

As Caladrius Biosciences merges with Cend Therapeutics to become Lisata Therapeutics, it’s leaving a coronary artery disease trial by the wayside. The biotech announced plans to shelve, at least for ...

Caladrius Blaze features not only the Shame Break system where you can view fantastic eye-candy cut-in graphics for both the playable characters and the bosses as they take damage and clothes are cut ...

Basking Ridge-based Caladrius Biosciences, a clinical-stage biopharmaceutical company that focuses on the development of cellular therapies designed to reverse, not manage disease, recently said the U ...

BASKING RIDGE, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...

Caladrius reported in May 2020 the compelling positive results of its ESCaPE-CMD Phase 2a study of CLBS16 for the treatment of coronary microvascular dysfunction (“CMD”), a disease that continues to ...

Combined company to be renamed Lisata Therapeutics upon transaction closing Combination will create a financially sound Nasdaq-listed company with a diverse product development pipeline, strong ...